Cellply – Fesr programme 2021-2027

Cellply is a company that develops analytical instruments for the pharmaceutical and life science industries. Cellply has developed the new VivaCyte® platform, the first applications of which involve the characterization of cancer cell therapies and immunotherapies.

Cellply’s solution makes it possible to accelerate the research and  development of these immunotherapies, and the company aims to carry out a product launch on an  international scale in 2023. As part of this marketing program, Cellply has planned to participate in a series of leading trade fairs in the specific field of CAR-Ts and therapies cells, in which it will participate with a booth. The target customers (biotech and pharmaceutical industries, research institutes and production sites) are mainly located abroad and particularly in the U.S., for this reason, the events in which Cellply will take part have an international scale and are held abroad. The  expected result is the growth of the sales pipeline and the subsequent acquisition of new customers.

The project is implemented thanks to European Funds from the Emilia-Romagna Region.